Stanley Leung

7PUBLICATIONS
63CO-AUTHORS
Molecular targetsPredictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Oct 02, 2025
Epigenetic and Transcriptional Programs Define Osteosarcoma Subtypes and Establish Targetable Vulnerabilities.

Eunice López-Fuentes, Andrew S Clugston, Alex G Lee

|Mar 26, 2025
Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer.

Rahul R Aggarwal, Jacqueline Vuky, David VanderWeele

|Sep 13, 2023
Osteosarcoma PDX-Derived Cell Line Models for Preclinical Drug Evaluation Demonstrate Metastasis Inhibition by Dinaciclib through a Genome-Targeted Approach.

Courtney R Schott, Amanda L Koehne, Leanne C Sayles

|Jul 05, 2023
UHRF1 is a mediator of KRAS driven oncogenesis in lung adenocarcinoma.

Kaja Kostyrko, Marta Román, Alex G Lee

|Aug 06, 2021
A Comprehensive Circulating Tumor DNA Assay for Detection of Translocation and Copy-Number Changes in Pediatric Sarcomas.

Avanthi Tayi Shah, Tej D Azad, Marcus R Breese

Pageof 2